A novel combination of serum markers in a multivariate model to help triage patients into “low-” and “high-risk” categories for prostate cancer

HIGHLIGHTS

• who: Christopher J. McNally from the Genomic Medicine Research Group, Ulster University, Coleraine, United Kingdom, Clinical Studies Group, Randox have published the research work: A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer, in the Journal: (JOURNAL)
• what: DeLong test was used to compare AUROCs for the model and tPSA; p and amp;lt;0.05 was considered significant. The authors investigated 19 serum markers involved in PCa (Supplementary 2). In the study , IL-8 was identified as a marker that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.